Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/03/2026 | Q4 | $158.8M | -- | -- | $0.66 | -- |
| 11/03/2025 | Q3 | $154.4M | $138.3M | $0.40 | $0.63 | -$0.23 |
| 08/11/2025 | Q2 | $144.2M | $143.6M | $0.27 | $0.58 | -$0.31 |
| 05/06/2025 | Q1 | $114.4M | $97.8M | -$0.20 | $0.03 | -$0.23 |
| 03/04/2025 | Q4 | $130.8M | $128.2M | -$0.02 | -- | -- |
| 11/07/2024 | Q3 | $142.3M | $137.5M | $3.27 | -- | -- |
| 08/06/2024 | Q2 | $137.4M | $140.8M | $0.26 | -- | -- |
| 05/07/2024 | Q1 | $110.3M | $124.3M | $0.40 | -- | -- |
| 03/05/2024 | Q4 | $127.7M | $134.9M | -$0.04 | -- | -- |
| 11/07/2023 | Q3 | -- | $145.3M | $0.05 | -- | -- |
| 08/08/2023 | Q2 | -- | $148M | $0.32 | -- | -- |
| 05/09/2023 | Q1 | -- | $115.5M | -$0.20 | -- | -- |
| 03/06/2023 | Q4 | -- | $137.2M | -$4.09 | -- | -- |
| 11/08/2022 | Q3 | -- | $130M | -$0.19 | -- | -- |
| 08/09/2022 | Q2 | -- | $131.5M | $0.19 | -- | -- |
| 05/10/2022 | Q1 | -- | $98.8M | -$0.15 | -- | -- |
| 03/01/2022 | Q4 | -- | $113M | -$0.03 | -- | -- |
| 11/02/2021 | Q3 | -- | $130.1M | $0.22 | -- | -- |
| 08/03/2021 | Q2 | -- | $154.5M | $0.27 | -- | -- |
| 05/03/2021 | Q1 | -- | $116.1M | -$0.12 | -- | -- |
| 03/02/2021 | Q4 | -- | $115.6M | $0.20 | -- | -- |
| 11/04/2020 | Q3 | -- | $118.4M | $1.58 | -- | -- |
| 08/04/2020 | Q2 | -- | $141.6M | $0.05 | -- | -- |
| 05/05/2020 | Q1 | -- | $121.9M | -$0.18 | -- | -- |
| 02/25/2020 | Q4 | -- | $141.3M | $2.52 | -- | -- |
| 10/29/2019 | Q3 | -- | $144.8M | $0.29 | -- | -- |
| 07/30/2019 | Q2 | -- | $200.9M | $0.90 | -- | -- |
| 05/09/2019 | Q1 | -- | $150.5M | $0.35 | -- | -- |
| 03/18/2019 | Q4 | -- | $164.5M | -$3.97 | -- | -- |
| 11/01/2018 | Q3 | -- | $167.1M | $0.61 | -- | -- |
| 07/31/2018 | Q2 | -- | $172.9M | $0.52 | -- | -- |
| 05/01/2018 | Q1 | -- | $122.5M | -$0.18 | -- | -- |
| 02/27/2018 | Q4 | -- | $141.3M | $0.03 | -- | -- |
| 11/07/2017 | Q3 | -- | $131.5M | $0.31 | -- | -- |
| 08/03/2017 | Q2 | -- | $144.9M | $0.29 | -- | -- |
| 05/02/2017 | Q1 | -- | $118.7M | -$0.23 | -- | -- |
| 03/02/2017 | Q4 | -- | $106.6M | -$3.97 | -- | -- |
| 11/07/2016 | Q3 | -- | $114.6M | -$0.58 | -- | -- |
| 08/09/2016 | Q2 | -- | $136M | -$8.96 | -- | -- |
| 05/03/2016 | Q1 | -- | $126.3M | -$0.28 | -- | -- |
| 03/01/2016 | Q4 | -- | $139.1M | $0.32 | -- | -- |
L.B. Foster Co. reported $138.3M worth of top line sales in its most recent quarter.
L.B. Foster Co. announced earnings per share of $0.40 which represents a miss of analyst forecast a $0.63 per share.
L.B. Foster Co. reported $30.4M that represents $2.79 per share over the last quarter.
L.B. Foster Co.'s earnings are forecast to decrease from $3.89 per share to $1.12 per share next year representing a decrease of -71.19%.
L.B. Foster Co.'s next earnings date is March 3, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.